Annals of Oncology
Open Access Publication
Barcenas, C H; Bose, R; and et al., "Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: The CONTROL trial." Annals of Oncology. 31, 9. 1223 - 1230. (2020).
ICTS (Institute of Clinical and Translational Sciences)